01 / ATLAS

What it is

MOTS-C is a 16-amino-acid peptide associated with a mitochondrial DNA sequence. It is investigated as a metabolic signal. [1]

02 / ATLAS

How it works

Experiments described effects on folate and purine metabolism, with AICAR accumulation and activation of AMPK, a regulator of cellular energy balance. [1]

03 / ATLAS

What research shows

The foundational study investigated metabolism and insulin sensitivity in cells and mice. These observations do not establish efficacy for weight loss, athletic performance or longevity in humans. [1]

04 / ATLAS

Study data

Lee et al., 2015, Cell Metabolism: experimental research using cell and animal models. The insulin-resistance findings are not a clinical trial of injectable products marketed under this name. [1]

05 / ATLAS

Safety and observed adverse reactions

The FDA identifies gaps in human data and potential immune-response and impurity risks. [2]

A molecule’s natural occurrence does not guarantee the safety of administering it as an external product.

06 / ATLAS

Research status

This entry relies on predominantly preclinical evidence. Research on the natural molecule or analogues must be distinguished from validation of a particular product.

07 / REFERENCES

Studies and sources

  1. Lee et al. · MOTS-C and metabolic homeostasis (2015) ↗Original research · Cell Metabolism
  2. FDA · Safety information for MOTS-C ↗Official assessment · United States
Back to the atlasFurther information / Contact